Luis Borges

Insider Reports History

Entity
Individual
Location
Two Corporate Drive, C/O Five Prime Therapeutics, Inc., South San Francisco, CA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Luis Borges:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Century Therapeutics, Inc. Chief Scientific Officer Common Stock 257K $382K $1.49 Apr 3, 2023 Direct
Metagenomi, Inc. Chief Scientific Officer Common Stock 69.3K $200K $2.88 Apr 1, 2024 Direct
Metagenomi, Inc. Chief Scientific Officer Stock Option (Right to Buy) 291K Apr 1, 2024 Direct
Century Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 0 Apr 3, 2023 Direct

Insider Reports Filed by Luis Borges

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MGX Metagenomi, Inc. Apr 1, 2024 2 $0 4 Apr 3, 2024 Chief Scientific Officer
MGX Metagenomi Technologies, LLC Feb 8, 2024 0 $0 3 Feb 8, 2024 Chief Scientific Officer
IPSC Century Therapeutics, Inc. Apr 3, 2023 2 $7.68K 4 Apr 5, 2023 Chief Scientific Officer
IPSC Century Therapeutics, Inc. Mar 21, 2023 9 -$179K 4 Mar 23, 2023 Chief Scientific Officer
IPSC Century Therapeutics, Inc. Feb 2, 2023 4 $0 4 Feb 6, 2023 Chief Scientific Officer
IPSC Century Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Chief Scientific Officer
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 Chief Scientific Officer